生命科学资讯

Prelude Therapeutics divulges new JAK2 inhibitors

Amgen describes new GTPase KRAS mutant inhibitors

New CDK2 and CDK4 degradation inducers disclosed in Nikang Therapeutics patent

Immuse Therapeutics discovers new LRRK2 inhibitors

Pfizer adds heft to obesity pipeline in $2B Yaopharma deal

Crescent, Kelun in two-way deal, including PD-1/VEGF bispecific

Aimedbio debuts with $48M Kosdaq IPO

Kazia raises AU$50M to advance PI3K/mTOR inhibitor paxalisib

14 psoriasis therapies projected to launch in China by 2027

ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data

GSK goes away, Ideaya synthetic lethality bids in-house again

New antibody-drug conjugates disclosed in Genome & Co. patent

Merck Sharp & Dohme discovers new GTPase KRAS degradation inducers

Other news to note for Dec. 8, 2025

Regulatory actions for Dec. 8, 2025

Viatris monetizes equity stake in Biocon, gets $400M cash

GSK goes away, Ideaya synthetic lethality bids in-house again

Mirum adds to rare live disease portfolio with $820M Bluejay buy

ASH 2025: Speeding AML research with MRD surrogate endpoint

Med-tech gainers and losers for Dec. 1-5, 2025